One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

Nutcracker Therapeutics and Elegen see their mission as delivering scalable and low-cost RNA manufacturing for individualized therapies.

Life science researchers have developed tools that scan millions of papers weekly for signs of fraud, but detection remains challenging.

A novel optogenetic screening platform enables a high-throughput screen and identified several integrated stress response-potentiating compounds.

The Wacker Biotechnology Center is in Munich, where the company has been conducting fundamental research for over a century.

The portrayal of uncaring scientists without any thought for the animals being used in their research is far from the truth.

For decades, the story of Alzheimer’s research has been dominated by a battle between amyloid-beta and tau amyloids, both of which can kill neurons and impact the brain’s abil ...

Results reveal that weight loss has significant effects on cellular processes that are known to affect metabolic health and ...

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...

Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm ...

Biopharma got perilously close to having demand for uniquely skilled and experienced workers outstrip supply during the COVID ...

Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...